# Methylprednisolone Taper After Total Knee Replacement

> **NCT05859269** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 101 (actual)

## Conditions studied

- Knee Arthritis

## Interventions

- **DRUG:** Methylprednisolone
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT05859269
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-16
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-07-23
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05859269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05859269, "Methylprednisolone Taper After Total Knee Replacement". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05859269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*